GlassScriptPhysician profile
Sanoj Punnen
NPI 1205137387
$47,858.59
in general payments reported to CMS, 2019-2025
35 companies · $8,511 in 2025
The $8,511 reported for 2025 was more than what 93% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $1,529 · 2021: $1,024 · 2022: $9,279 · 2023: $13K · 2024: $14K · 2025: $8,511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Honoraria: $7,500 · Travel and Lodging: $4,784 · Food and Beverage: $3,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,015.00 |
| Honoraria | $7,500.00 |
| Travel and Lodging | $4,783.94 |
| Food and Beverage | $3,358.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $26,337.03 | 2023-2025 | Illuccix |
| Progenics Pharmaceuticals, INC. | $8,086.26 | 2022 | |
| Pfizer INC. | $3,699.20 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $2,598.02 | 2024-2025 | Erleada, Carvykti, Darzalex |
| Astellas Pharma US INC | $1,945.38 | 2019-2024 | Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $1,516.65 | 2020-2023 | |
| Foundation Medicine, INC. | $750.00 | 2021 | |
| Boston Scientific Corporation | $624.33 | 2019-2024 | |
| Integra Lifesciences Corporation | $480.92 | 2021-2022 | |
| Urogen Pharma, INC. | $326.38 | 2021-2025 | Jelmyto |
| Myriad Genetic Laboratories, INC. | $209.47 | 2022-2023 | Prolaris |
| Axonics, INC. | $164.77 | 2022-2023 | Axonics |
| Medtronic, INC. | $151.97 | 2023 | Signia |
| Sumitomo Pharma America, INC. | $132.05 | 2023-2025 | Orgovyx, Gemtesa |
| Ferring Pharmaceuticals INC. | $121.64 | 2024-2025 | Adstiladrin |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $115.95 | 2019 | |
| Daiichi Sankyo INC. | $96.58 | 2024-2025 | Enhertu |
| Abbvie INC. | $75.44 | 2019-2025 | |
| Janssen Biotech, INC. | $74.35 | 2020-2025 | Erleada |
| Verity Pharmaceuticals INC. | $47.07 | 2025 | Tlando |
| Astrazeneca Pharmaceuticals LP | $35.21 | 2024 | Lynparza |
| Puma Biotechnology, INC. | $29.66 | 2024-2025 | |
| Intuitive Surgical, INC. | $25.90 | 2019 | |
| Edap Technomed INC | $25.00 | 2021 | |
| Olympus America INC. | $24.86 | 2023 | Cysto-Nephro Videoscope |
| Tersera Therapeutics LLC | $24.57 | 2024 | Zoladex |
| Teleflex LLC | $23.16 | 2025 | Deknatel |
| Blue Earth Diagnostics | $19.76 | 2024 | |
| Urovant Sciences INC | $19.08 | 2022 | |
| Alexion Pharmaceuticals, INC. | $18.87 | 2024 | Ultomiris |
| Angiodynamics, INC. | $16.63 | 2025 | Nanoknife |
| Adaptive Biotechnologies Corporation | $16.23 | 2025 | Clonoseq |
| Tactile Systems Technology INC | $14.93 | 2024 | Flexitouch Plus, Entre Plus |
| Laborie Medical Technologies Corp. | $11.27 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanoj Punnen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.